How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies

Current opinion in endocrinology, diabetes, and obesity

Volumn 21, Issue 5, 2014, Pages 394-404

  Spencer, Carole ^a   LoPresti, Jonathan ^a   Fatemi, Shireen ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THYROGLOBULIN; TUMOR MARKER;

BLOOD; HUMAN; IMMUNOLOGY; IMMUNORADIOMETRIC ASSAY; PHYSIOLOGIC MONITORING; POSTOPERATIVE PERIOD; PROCEDURES; PROGNOSIS; THYROID FUNCTION TEST; THYROID NEOPLASMS; THYROIDECTOMY;

AUTOANTIBODIES; HUMANS; IMMUNORADIOMETRIC ASSAY; MONITORING, PHYSIOLOGIC; POSTOPERATIVE PERIOD; PROGNOSIS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 85027953693     PISSN: None     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000092     Document Type: Review

References (0)